echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Bulletin on September 20, 2021: The number of people covered by my country’s new crown vaccination reached 1.1 billion; the number of deaths in a U.S. state last year exceeded the number of births for the first time; the real-world results of Israel’s third booster dose of the new crown vaccine were released, and the confirmed infection rate dropped by 11 times. 20 times lower incidence of severe illness

    Bulletin on September 20, 2021: The number of people covered by my country’s new crown vaccination reached 1.1 billion; the number of deaths in a U.S. state last year exceeded the number of births for the first time; the real-world results of Israel’s third booster dose of the new crown vaccine were released, and the confirmed infection rate dropped by 11 times. 20 times lower incidence of severe illness

    • Last Update: 2021-09-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    As of 7:01 on September 20, 2021, Beijing time, Worldometers world real-time statistics show that the cumulative number of confirmed new coronary pneumonia ( COVID-19 ) cases worldwide has exceeded 229.


    New Coronary Pneumonia COVID-19 Briefing on September 19, 2021: 31 new confirmed cases in 4 places in Fujian; Sinopharm inactivated vaccine in children’s FDA

    The number of people covered by my country's new crown vaccination reaches 1.


    The number of people covered by my country's new crown vaccination reaches 1.


    As of September 18, 31 provinces (autonomous regions, municipalities) and the Xinjiang Production and Construction Corps had reported a total of 217.


    In the next step, the relevant departments will base on the needs of epidemic prevention and control and the needs of the people, carefully organize and implement follow-up vaccination work, further increase the coverage of the vaccination population, and effectively protect the health of the people


    The latest research of Zhong Nanshan's team found that the intermediate host of the new coronavirus may be rodents

    Recently, a research team led by Academician Zhong Nanshan and dedicated to the National Key Laboratory of Respiratory Diseases in Allergic Reaction and Immunity Research, and organized by Professor Tao Ailin of the Second Affiliated Hospital of Guangzhou Medical University, published the title "SARS-CoV-2: Origin" in the Journal of Healthcare.


    immunity

    The study attempts to decipher the intermediate host source and allergenicity of the new coronavirus, as well as how the virus appeared, and how and when it will disappear


    Cluster infection occurred in Pfizer Asia Pacific branch in Singapore

    Singapore Pfizer Asia Pacific division had the accumulation infection infection

    According to the Ministry of Health of Singapore, a cluster of new coronavirus infections occurred in the Asia Pacific branch of Pfizer Pharmaceuticals in Singapore.


    According to the Ministry of Health of Singapore, a cluster of new coronavirus infections occurred in the Asia Pacific branch of Pfizer Pharmaceuticals in Singapore.


    The cumulative number of confirmed cases of new coronary pneumonia in the United States exceeds 42.


    The death toll in a U.


    The number of deaths in a U.


    Under the influence of the new crown pneumonia epidemic, the number of deaths in Alabama in the United States in 2020 exceeds the number of births


    Survey of more than 30,000 new confirmed cases in India: Nearly 90% of Mumbai’s population has COVID-19 antibodies

    According to the latest data released by the Indian Ministry of Health on the 19th, the number of confirmed cases of new coronary pneumonia in India rose to 33,448,163


    Reuters news on September 17, according to the results of a citizen survey released by the Mumbai Municipal Authority (BMC) on Friday, nearly 90% of the population of Mumbai, the financial capital of India, has COVID-19 antibodies


    Over 20,000 new confirmed cases in Russia and nearly 47.


    Over 20,000 new confirmed cases in Russia and nearly 47.
    5 million citizens complete the first dose of vaccination

    According to the latest data released on the official website of Russia's new crown virus epidemic prevention on the 19th, Russia has newly confirmed cases of new crown pneumonia in 20174, a total of 7274928 confirmed cases, 793 new cases of new crown pneumonia, and a total of 19,218 deaths
    .

    Russian Satellite News Agency reported on September 17 that Russian Health Minister Mikhail Murashko stated that nearly 47.
    5 million people have completed the first dose of the new crown vaccination and 41 million people have been completely vaccinated
    .

    10,040 new confirmed cases in Vietnam are conditionally approved for emergency use of the new crown vaccine developed by Cuba

    10,040 new confirmed cases in Vietnam are conditionally approved for emergency use of the new crown vaccine developed by Cuba

    According to the Viet News Agency, from 17:00 on September 18 to 17:00 on September 19, Vietnam reported 10,040 new confirmed cases, including 15 imported cases, 10025 confirmed local cases, and a total of 687,063 confirmed cases; new deaths There were 233 cases and a total of 17090 deaths
    .

    According to the Viet News Agency, the Ministry of Health of Vietnam has issued Decision No.
    4471 on conditional approval of the Abdala Covid-19 vaccine developed in Cuba on September 17, 2021 to meet urgent needs in the prevention and control of the Covid-19 epidemic
    .

    U.
    S.
    FDA consultant supports reducing the scope of Pfizer's booster vaccination to a limited population

    U.
    S.
    FDA consultant supports reducing the scope of Pfizer's booster vaccination to a limited population

    US Food and Drug Administration Administration (FDA) advisory panel of experts said that Pfizer and BioNTech SE's new crown vaccine booster vaccination should be those most likely to suffer from serious diseases
    .
    The FDA and Pfizer initially proposed to approve booster injections for people 16 and older
    .

    US Food and Drug Administration Administration (FDA) advisory panel of experts said that Pfizer and BioNTech SE's new crown vaccine booster vaccination should be those most likely to suffer from serious diseases
    .
    The FDA and Pfizer initially proposed to approve booster injections for people 16 and older
    .
    manage

    Fauci: The data used to confirm the feasibility of the new crown vaccine booster injection will be released in a few weeks

    Fauci: to confirm the new crown vaccine booster needle feasibility data will be released in a few weeks Forge: to confirm the new crown vaccine booster shot feasibility data will be released in a few weeks

    According to a Reuters report on September 19, local time, the White House Chief Medical Advisor Dr.
    Anthony Fauci said that data used to confirm the feasibility of the new crown vaccine booster vaccine produced by Johnson & Johnson and Modena will be released within a few weeks.

    .

    According to a Reuters report on September 19, local time, the White House Chief Medical Advisor Dr.
    Anthony Fauci said that data used to confirm the feasibility of the new crown vaccine booster vaccine produced by Johnson & Johnson and Modena will be released within a few weeks.

    .

    NEJM: The real-world results of Israel’s third booster dose of the new crown vaccine are released, the confirmed infection rate has dropped by 11 times, and the incidence of severe illness is 20 times lower.

    NEJM: Real-world results of Israel’s third booster dose of new crown vaccine are released, the confirmed infection rate has dropped by 11 times, and the incidence of severe illness is 20 times lower.
    Times, the incidence of severe illness is 20 times lower

    On July 30, 2021, Israel is the first country in the world to provide a third dose of Pfizer vaccine to all people 60 years of age or older who have received two doses of the vaccine at least 5 months ago
    .
    The results of this study clearly show that even for the currently dominant delta variants, the vaccine booster has obvious protective effects
    .
    Among people over 60 years of age, the confirmed infection rate of the booster shot was 11.
    3 times lower than the confirmed infection rate of the two shots of the vaccine, and the incidence of severe cases of the booster shot was 19.
    5 times lower than the incidence of severe cases of the two shots of vaccine
    .

    On July 30, 2021, Israel is the first country in the world to provide a third dose of Pfizer vaccine to all people 60 years of age or older who have received two doses of the vaccine at least 5 months ago
    .
    The results of this study clearly show that even for the currently dominant delta variant, the vaccine booster has obvious protective effects
    .
    Among people over 60 years of age, the confirmed infection rate of the booster shot was 11.
    3 times lower than the confirmed infection rate of the two shots of the vaccine, and the incidence of severe cases of the booster shot was 19.
    5 times lower than the incidence of severe cases of the two shots of vaccine
    .


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.